Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of COMPUGEN LTD patents

Patents where

Current Assignee

Name

‌

COMPUGEN LTD

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9409987 Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer	Patent 9409987 was granted and assigned to COMPUGEN LTD on August, 2016 by the United States Patent and Trademark Office.		‌ COMPUGEN LTD	United States Patent and Trademark Office	9409987	August 9, 2016
‌ US Patent 7368548 Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer	Patent 7368548 was granted and assigned to COMPUGEN LTD on May, 2008 by the United States Patent and Trademark Office.		‌ COMPUGEN LTD	United States Patent and Trademark Office	7368548	May 6, 2008
‌ US Patent 7553948 Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer	Patent 7553948 was granted and assigned to COMPUGEN LTD on June, 2009 by the United States Patent and Trademark Office.		‌ COMPUGEN LTD	United States Patent and Trademark Office	7553948	June 30, 2009
‌ US Patent 7939634 Polynucleotides encoding polypeptides and methods using same	Patent 7939634 was granted and assigned to COMPUGEN LTD on May, 2011 by the United States Patent and Trademark Office.		‌ COMPUGEN LTD	United States Patent and Trademark Office	7939634	May 10, 2011
‌ US Patent 7569662 Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer	Patent 7569662 was granted and assigned to COMPUGEN LTD on August, 2009 by the United States Patent and Trademark Office.		‌ COMPUGEN LTD	United States Patent and Trademark Office	7569662	August 4, 2009
‌ US Patent 7745391 Human thrombospondin polypeptide	Patent 7745391 was granted and assigned to COMPUGEN LTD on June, 2010 by the United States Patent and Trademark Office.		‌ COMPUGEN LTD	United States Patent and Trademark Office	7745391	June 29, 2010
‌ US Patent 7601692 MCP-1 splice variants and methods of using same	Patent 7601692 was granted and assigned to COMPUGEN LTD on October, 2009 by the United States Patent and Trademark Office.		‌ COMPUGEN LTD	United States Patent and Trademark Office	7601692	October 13, 2009
‌ US Patent 8492329 Bioactive peptides and methods of using same	Patent 8492329 was granted and assigned to COMPUGEN LTD on July, 2013 by the United States Patent and Trademark Office.		‌ COMPUGEN LTD	United States Patent and Trademark Office	8492329	July 23, 2013
‌ US Patent 9617336 C10RF32 antibodies, and uses thereof for treatment of cancer	Patent 9617336 was granted and assigned to COMPUGEN LTD on April, 2017 by the United States Patent and Trademark Office.	‌ COMPUGEN LTD	‌ COMPUGEN LTD	United States Patent and Trademark Office	9617336	April 11, 2017
‌ US Patent 9555087 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics	Patent 9555087 was granted and assigned to COMPUGEN LTD on January, 2017 by the United States Patent and Trademark Office.	‌ COMPUGEN LTD	‌ COMPUGEN LTD	United States Patent and Trademark Office	9555087	January 31, 2017
‌ US Patent 7842459 Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis	Patent 7842459 was granted and assigned to COMPUGEN LTD on November, 2010 by the United States Patent and Trademark Office.		‌ COMPUGEN LTD	United States Patent and Trademark Office	7842459	November 30, 2010
‌ US Patent 10550173 PVRIG polypeptides and methods of treatment	Patent 10550173 was granted and assigned to COMPUGEN LTD on February, 2020 by the United States Patent and Trademark Office.	‌ COMPUGEN LTD	‌ COMPUGEN LTD	United States Patent and Trademark Office	10550173	February 4, 2020
‌ US Patent 8415455 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics	Patent 8415455 was granted and assigned to COMPUGEN LTD on April, 2013 by the United States Patent and Trademark Office.		‌ COMPUGEN LTD	United States Patent and Trademark Office	8415455	April 9, 2013
‌ US Patent 10098934 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics	Patent 10098934 was granted and assigned to COMPUGEN LTD on October, 2018 by the United States Patent and Trademark Office.	‌ COMPUGEN LTD	‌ COMPUGEN LTD	United States Patent and Trademark Office	10098934	October 16, 2018
‌ US Patent 9714289 Anti-PVRIG antibodies and methods of use	Patent 9714289 was granted and assigned to COMPUGEN LTD on July, 2017 by the United States Patent and Trademark Office.	‌ COMPUGEN LTD	‌ COMPUGEN LTD	United States Patent and Trademark Office	9714289	July 25, 2017
‌ US Patent 10351625 Anti-PVRIG antibodies and methods of use	Patent 10351625 was granted and assigned to COMPUGEN LTD on July, 2019 by the United States Patent and Trademark Office.	‌ COMPUGEN LTD	‌ COMPUGEN LTD	United States Patent and Trademark Office	10351625	July 16, 2019
‌ US Patent 10227408 Anti-PVRIG antibodies and methods of use	Patent 10227408 was granted and assigned to COMPUGEN LTD on March, 2019 by the United States Patent and Trademark Office.	‌ COMPUGEN LTD	‌ COMPUGEN LTD	United States Patent and Trademark Office	10227408	March 12, 2019
‌ US Patent 11220542 Anti-PVRIG antibodies and methods of use	Patent 11220542 was granted and assigned to COMPUGEN LTD on January, 2022 by the United States Patent and Trademark Office.	‌ COMPUGEN LTD	‌ COMPUGEN LTD	United States Patent and Trademark Office	11220542	January 11, 2022
‌ US Patent 8987191 Bioactive peptides and methods of using same	Patent 8987191 was granted and assigned to COMPUGEN LTD on March, 2015 by the United States Patent and Trademark Office.	‌ COMPUGEN LTD	‌ COMPUGEN LTD	United States Patent and Trademark Office	8987191	March 24, 2015
‌ US Patent 9255132 Angiopoietin derived peptides	Patent 9255132 was granted and assigned to COMPUGEN LTD on February, 2016 by the United States Patent and Trademark Office.	‌ COMPUGEN LTD	‌ COMPUGEN LTD	United States Patent and Trademark Office	9255132	February 9, 2016
‌ US Patent 9428586 Heparanase splice variant	Patent 9428586 was granted and assigned to COMPUGEN LTD on August, 2016 by the United States Patent and Trademark Office.		‌ COMPUGEN LTD	United States Patent and Trademark Office	9428586	August 30, 2016
‌ US Patent 7884180 Peptides which bind to G protein-coupled receptors	Patent 7884180 was granted and assigned to COMPUGEN LTD on February, 2011 by the United States Patent and Trademark Office.		‌ COMPUGEN LTD	United States Patent and Trademark Office	7884180	February 8, 2011
‌ US Patent 8349801 Peptide ligands for G-protein coupled receptors	Patent 8349801 was granted and assigned to COMPUGEN LTD on January, 2013 by the United States Patent and Trademark Office.		‌ COMPUGEN LTD	United States Patent and Trademark Office	8349801	January 8, 2013
‌ US Patent 7758862 Hepatocyte growth factor receptor splice variants and methods of using same	Patent 7758862 was granted and assigned to COMPUGEN LTD on July, 2010 by the United States Patent and Trademark Office.		‌ COMPUGEN LTD	United States Patent and Trademark Office	7758862	July 20, 2010
‌ US Patent 11623955 Anti-PVRIG antibodies and methods of use	Patent 11623955 was granted and assigned to COMPUGEN LTD on April, 2023 by the United States Patent and Trademark Office.	‌ COMPUGEN LTD	‌ COMPUGEN LTD	United States Patent and Trademark Office	11623955	April 11, 2023

Results per page:

47 results

0 selected

47 results

0 selected